Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00927693 · ClinicalTrials.gov registry record · NA
Early Identification of Subclinical Atherosclerosis Using Non-Invasive Imaging Research (EISNER)
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2,137
- Enrollment target
NCT00927693 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 2,137 participants.
The verdict
NCT00927693, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,137 participants
- Enrollment target
Study Summary
Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research (EISNER) is a multi-study research program being conducted at Cedars-Sinai Medical Center. The principal objective of this randomized trial (referred to as "Study 1") is to assess whether coronary artery calcium (CAC) scanning provides clinical benefit thus improving patient outcomes in asymptomatic subjects with intermediate coronary artery disease (CAD) risk. Additionally, the study is designed to assess the value of combining the CAC scan with the Framingham risk score (FRS) and measurements of serum or plasma biomarkers to predict outcomes.
Interventions
- OTHER Coronary Artery Calcium (CAC) Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,137 participants |
| Start Date | 2001-02 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00927693
The ClinicalTrials.gov registry entry for NCT00927693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Coronary Artery Calcium (CAC) Scan is the first listed.
NCT00927693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00927693 about?
NCT00927693 is a clinical study titled "Early Identification of Subclinical Atherosclerosis Using Non-Invasive Imaging Research (EISNER)". Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research (EISNER) is a multi-study research program being conducted at Cedars-Sinai Medical Center. The principal objective of this randomized trial (referred to as "Study 1") is to assess whether coronary artery calcium (CA...
What is the current status of trial NCT00927693?
This trial is currently completed. It is a NA study. The enrollment target is 2,137 participants. The study started on 2001-02. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00927693?
The interventions under investigation include: Coronary Artery Calcium (CAC) Scan (OTHER).
Who is sponsoring clinical trial NCT00927693?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.